Caption Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Caption Management's VRTX Position: Q1 2026 in Review
Caption Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 200 shares worth $89.3K. The stake represents ﹤0.01% of the portfolio and ranks #1401 among its holdings. This is a return to the name: Caption Management previously reported a position in VRTX as recently as Q1 2024.
Caption Management first reported a position in VRTX in Q3 2021 and has held it in 5 quarters since. The position peaked at $12.6M in Q1 2022. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Caption Management held 200 shares of Vertex Pharmaceuticals worth $89.3K as of Q1 2026.
- Vertex Pharmaceuticals was a new Caption Management position in Q1 2026.
- Vertex Pharmaceuticals made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1401 holding.
- Caption Management first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 5 quarters since.
- Caption Management's Vertex Pharmaceuticals position peaked at $12.6M in Q1 2022.
- 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.